Next Generation News and Research

RSS

ALSAM Foundation invests additional $2 million for drug discovery and development projects

The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.

20 Sep 2018

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.

20 Sep 2018

Scientists better understand influenza virus and how it spreads

The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.

20 Sep 2018

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion, Inc. signed an 'Incubation' agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.

20 Sep 2018

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy.

19 Sep 2018

Henry Ford Health System receives $600k grant to study genetic makeup of gliomas

Henry Ford Health System's Department of Neurosurgery was awarded a $600,000 grant by the Department of Defense to study the genetic makeup of gliomas, a type of brain cancer, in hope of identifying new therapies.

19 Sep 2018

Potential drugs to treat neurodegenerative diseases garner $3 million grant

A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson's, ALS, Alzheimer's and Creutzfeldt-Jakob disease.

18 Sep 2018

Researchers use CRISPR to identify gene that helps cells resist flavivirus infection

UT Southwestern researchers today report the first use of CRISPR genome-wide screening to identify a gene that helps cells resist flavivirus infection. That nasty class of pathogens includes West Nile virus, dengue fever, Zika virus, and yellow fever.

18 Sep 2018

Children's National and NIAID launch pediatric clinical research partnership

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and Children's National Health System, a pediatric academic medical center in Washington, D.C., have launched a clinical research partnership devoted to treating and preventing allergic, immunologic and infectious diseases in children.

17 Sep 2018

People battling substance use disorders may benefit from meth-relapse prevention compound

New research raises the possibility that a wider group of people battling substance use disorders may benefit from a Scripps Research-developed relapse-prevention compound than previously thought.

17 Sep 2018

The Digital Health Platform That’s Tackling Chronic Health Conditions

An interview with Simon Pickup from Liva Healthcare about the Liva digital health platform and how it is changing the lives of patients with chronic diseases.

From Liva Healthcare UK 14 Sep 2018

New project aims to increase patient willingness to take life-saving oral drugs

A new collaboration grant to scientists from Discovery BioMed, Inc. and the Monell Center will support development of next-generation screening technologies to enable identification of bitter taste blockers.

14 Sep 2018

Rare antibodies could be key ingredients in therapeutics capable of neutralizing many Ebola types

Two new studies by scientists at Scripps Research are bringing Ebola virus's weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection--not only for Ebola virus, but for other closely related pathogens as well.

13 Sep 2018

Is ‘precision medicine’ the answer to cancer? Not precisely.

Facing incurable breast cancer at age 55, MaryAnne DiCanto put her faith in "precision medicine" — in which doctors try to match patients with drugs that target the genetic mutations in their tumors. She underwent repeated biopsies to identify therapies that might help.

13 Sep 2018

Wearable monitor uses AI to diagnose heart rhythm and respiratory problems

A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.

12 Sep 2018

New research on molecular mechanistic understanding of drug delivery and drug delivery systems

Today, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announces the publication of a new research paper "Entangled Conditional Adversarial Autoencoder for de-novo Drug Discovery" in Molecular Pharmaceutics, the leading American Chemical Society journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems

12 Sep 2018

Discovery of unusual biosynthetic pathways could aid in the search for new natural products

Bacteria are master engineers of small, biologically useful molecules. A new study in Nature Communications has revealed one of the tricks of this microbial trade: synthesizing and then later inserting a nitrogen-nitrogen bond, like a prefabricated part, into a larger molecule.

12 Sep 2018

Next Generation News and Research

ALSAM Foundation invests additional $2 million for drug discovery and development projects

UK and European research collaborations receive vote of confidence by three major cancer charities

Scientists better understand influenza virus and how it spreads

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Henry Ford Health System receives $600k grant to study genetic makeup of gliomas

Potential drugs to treat neurodegenerative diseases garner $3 million grant

Researchers use CRISPR to identify gene that helps cells resist flavivirus infection

Children's National and NIAID launch pediatric clinical research partnership

People battling substance use disorders may benefit from meth-relapse prevention compound

The Digital Health Platform That’s Tackling Chronic Health Conditions

New project aims to increase patient willingness to take life-saving oral drugs

Rare antibodies could be key ingredients in therapeutics capable of neutralizing many Ebola types

Is ‘precision medicine’ the answer to cancer? Not precisely.

Wearable monitor uses AI to diagnose heart rhythm and respiratory problems

New research on molecular mechanistic understanding of drug delivery and drug delivery systems

Discovery of unusual biosynthetic pathways could aid in the search for new natural products

Increasing number of women learn about breast cancer diagnosis over the telephone

Scientists develop first DNA-based test for predicting risk of leukemia relapse

Researchers develop technology to help deconstruct surgeons' robotic surgery skills

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News